Vanda Pharmaceuticals (VNDA) Revenue Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -6.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.12% |
| Dec 31, 2025 | -3.91% |
| Sep 30, 2025 | -4.86% |
| Jun 30, 2025 | -6.53% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -7.87% |
| Sep 30, 2024 | -12.07% |
| Jun 30, 2024 | -9.41% |
| Mar 31, 2024 | -8.85% |
| Dec 31, 2023 | -12.53% |
| Sep 30, 2023 | -13.66% |
| Jun 30, 2023 | -9.53% |
| Mar 31, 2023 | 2.52% |
| Dec 31, 2022 | 1.91% |
| Sep 30, 2022 | 3.17% |
| Jun 30, 2022 | 2.92% |
| Mar 31, 2022 | 8.05% |
| Dec 31, 2021 | 8.64% |
| Sep 30, 2021 | 12.57% |
| Jun 30, 2021 | 12.77% |
| Mar 31, 2021 | 12.86% |
| Dec 31, 2020 | 15.18% |
| Sep 30, 2020 | 13.42% |
| Jun 30, 2020 | 13.94% |
| Mar 31, 2020 | 15.73% |
| Dec 31, 2019 | 16.79% |
| Sep 30, 2019 | 15.62% |
| Jun 30, 2019 | 17.91% |
| Mar 31, 2019 | 12.78% |
| Dec 31, 2018 | 18.53% |
| Sep 30, 2018 | 20.13% |
| Jun 30, 2018 | 19.74% |
| Mar 31, 2018 | 25.32% |
| Dec 31, 2017 | 42.29% |
| Sep 30, 2017 | 40.89% |
| Jun 30, 2017 | 57.03% |
| Mar 31, 2017 | 59.95% |
| Dec 31, 2016 | 63.30% |
| Sep 30, 2016 | 64.10% |
| Jun 30, 2016 | 63.00% |
| Mar 31, 2016 | 60.35% |
| Dec 31, 2015 | 59.02% |
| Sep 30, 2015 | 50.66% |
| Jun 30, 2015 | 48.76% |
| Mar 31, 2015 | 39.60% |
| Dec 31, 2014 | 22.46% |
| Sep 30, 2014 | 22.87% |
| Jun 30, 2014 | 13.49% |
| Mar 31, 2014 | 6.82% |
| Dec 31, 2013 | 56.45% |
| Sep 30, 2013 | 6.32% |
| Jun 30, 2013 | 75.39% |